Search Within

Advanced Practice Providers

  1. "CTCR Scholars"
Formats
  1. Meeting Abstract (58)
  2. Journal Article (37)
  3. Research Letter (5)
  4. Review (1)
Groups
  1. CTCR Scholars (101)
  2. Department of Medicine (97)
  3. Center for Hematologic Malignancies (91)
  4. Hematologic Malignancies, Division of (90)
  5. Bone Marrow Transplant (86)
  6. Survivorship Research (82)

More Groups

People
  1. Sergio Giralt (70)
  2. Gunjan Shah (52)
  3. Miguel-Angel Perales (52)
  4. Sean Devlin (49)
  5. Michael Scordo (43)
  6. Parastoo Dahi (43)

More People

Years
  1. 2025 (1)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (14)
  5. 2021 (14)
  6. 2020 (20)

More Years

Publications
  1. Blood (33)
  2. Biology of Blood and Marrow Transplantation (18)
  3. Blood Advances (6)
  4. Bone Marrow Transplantation (6)
  5. Journal of Clinical Oncology (5)
  6. Transplantation and Cellular Therapy (5)

More Publications

Publishers
  1. American Society of Hematology (39)
  2. Elsevier Inc. (25)
  3. Nature Publishing Group (9)
  4. American Society of Clinical Oncology (6)
  5. Taylor & Francis Group (4)
  6. American Association for Cancer Research (3)

More Publishers

Results (101)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Peri-transplant vitamin and micronutrient status in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Rodich, L.; Adintori, P. A.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Gossman, Z.; Shike, M.; Barker, J. N.; Jakubowski, A. A.; Kernan, N. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Humoral response to COVID-19 vaccination given pre-cellular therapy wanes in patients after cellular therapy: An argument for full reimmunization
    Meeting Abstract

    Shah, G. L.; Chung, D. J.; Tamari, R.; Politikos, I.; Jakubowski, A. A.; Marcello, L.; Doddi, S.; Ramanathan, L.; Pessin, M.; Palazzo, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
    Meeting Abstract

    Dahi, P. B.; Geyer, A.; Kenny, S.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant
    Journal Article

    Sola, M.; Bhatt, V.; Palazzo, M.; Cavalier, K. E.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D.; Dahi, P. B.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: A single-center experience
    Journal Article

    Pak, T. K.; Dixon, B. N.; Buege, M. J.; Dao, P. H.; Leary, M. H.; Jarrett, J. C.; Duggan, T. A.; Caron, P.; Falchi, L.; Hamlin, P.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Population pharmacokinetics of melphalan in a large cohort of autologous and allogeneic hematopoietic cell transplantation recipients: Towards individualized dosing regimens
    Journal Article

    Shah, G. L.; Boelens, J. J.; Carlow, D.; Lin, A.; Schofield, R.; Cruz Sitner, N.; Alperovich, A.; Ruiz, J.; Proli, A.; Dahi, P.; more...
    Clinical Pharmacokinetics (2022)

    Fulltext@MSK | Save
  • The effect of neutropenia and filgrastim (G-CSF) on cancer patients with coronavirus disease 2019 (COVID-19) infection
    Journal Article

    Zhang, A. W.; Morjaria, S.; Kaltsas, A.; Hohl, T. M.; Parameswaran, R.; Patel, D.; Zhou, W.; Predmore, J.; Perez-Johnston, R.; Jee, J.; more...
    Clinical Infectious Diseases (2022)

    Fulltext@MSK | Save
  • Atypical pathogens presenting with pulmonary consolidations detected by cell-free DNA next-generation sequencing in patients with hematologic malignancies
    Review

    Caldararo, M.; Algazaq, J.; Schmidt, E.; Joanow, A.; Mariano, A.; Predmore, J.; Politikos, I.; Cho, C.; Stein, E. M.; Wen, X.; more...
    Infectious Diseases in Clinical Practice (2022)

    Fulltext@MSK | Save
  • Timing and immune status after cellular therapies predict response to COVID-19 vaccines
    Meeting Abstract

    Tamari, R.; Politikos, I.; Knorr, D.; Vardhana, S.; Young, J.; Marcello, L.; Doddi, S.; Devlin, S. M.; Ramanathan, L.; Pessin, M. S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save